In Wolff-Parkinson-White Syndrome (WPW), presence of accessory conduits causes various signs and clinical conditions in patients. WPW syndrome is presently defined as a congenital defect involving the occurrence of abnormal conductive tissue between the atria and the ventricles in relation to supraventricular tachycardia (SVT). SVT is observed in this group of patients. WPW syndrome at high rates can be mixed with SVT. Calcium channel blockers (diltiazem, verapamil) that are one of the most preferred medicines for rate control in patients with SVT may lead to fatal risks in individuals with WPW syndrome. In our presentation, we studied, in parallel to the literature, the case of a patient who presents the WPW syndrome but who is followed as a SVT without performing the electrophysiological tests in parallel to the literature.
J. Exp. Clin. Med., 2013; 30:357-359
Emergency medicine; diltiazem; supra ventricular tachycardia; wolf parkinson white syndrome
Primary Language | English |
---|---|
Journal Section | Internal Medical Sciences |
Authors | |
Publication Date | February 5, 2014 |
Submission Date | January 15, 2013 |
Published in Issue | Year 2013 Volume: 30 Issue: 4 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.